Israel - hebraisk - Ministry of Health

abbvie biopharmaceuticals ltd, israel - fluorometholone - תרחיף לעין - fluorometholone 0.1 %w/v - fluorometholone - fluorometholone - to treat eye inflammation.

Israel - hebraisk - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

Israel - hebraisk - Ministry of Health

novartis israel ltd - diclofenac sodium - טיפות עיניים - diclofenac sodium 1 mg/ml - diclofenac - diclofenac - post-operative inflammation following cataract extraction. control of ocular pain and discomfort associated with corneal epithelial defects after laser excimer prk or accidental trauma.

Israel - hebraisk - Ministry of Health

novartis israel ltd - dexamethasone; neomycin as sulfate; polymyxin b sulfate - משחה לעין - dexamethasone 1 mg/g; neomycin as sulfate 3500 iu/g; polymyxin b sulfate 6000 iu/g - dexamethasone and antiinfectives - dexamethasone and antiinfectives - for the treatment of eye infections which are responsive to steroids, when an antibiotic is also needed.

Israel - hebraisk - Ministry of Health

novartis israel ltd - apraclonidine as hydrochloride - תמיסה לעין - apraclonidine as hydrochloride 5 mg/ml - apraclonidine - apraclonidine - short term adjunctive therapy in patients on maximally tolerated medical therapy who require additional itraocular pressure reduction.

Israel - hebraisk - Ministry of Health

abbvie biopharmaceuticals ltd, israel - brimonidine tartrate; timolol as maleate - תמיסה לעין - timolol as maleate 0.5 %w/v; brimonidine tartrate 0.2 %w/v - brimonidine - brimonidine - combigan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - dorzolamide as hydrochloride - תמיסה לעין - dorzolamide as hydrochloride 20 mg/ml - dorzolamide - dorzolamide - for the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma.

Israel - hebraisk - Ministry of Health

novartis israel ltd - brinzolamide - תרחיף לעין - brinzolamide 1 % - brinzolamide - brinzolamide - alcon azopt is indicated to decrease elevated intraocular pressure in: ocular hypertension open-angle glaucoma as monotherapy in patients unresponsive to beta-blockers or in patients in whom beta-blockers are contra-indicated or as adjunctive therapy to beta-blockers.

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - timolol as maleate - טיפות עיניים - timolol as maleate 5 mg/ml - timolol - timolol - for the reduction of elevated intraocular pressure may be used in patients with chronic open-angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension

Israel - hebraisk - Ministry of Health

abbvie biopharmaceuticals ltd, israel - bimatoprost; timolol as maleate - טיפות עיניים - bimatoprost 0.3 mg/ml; timolol as maleate 5 mg/ml - timolol - timolol - reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.